Brief: Spectral AI To Pursue De Novo Classification From FDA For Use Of Deepview System
28/01/2025 16:04
Jan 28 (Reuters) - Spectral AI Inc MDAI.O :
* SPECTRAL AI COMPLETES PEDIATRIC ENROLLMENT IN EMERGENCY
DEPARTMENTS FOR U.S. BURN PIVOTAL STUDY
* SPECTRAL AI: TO PURSUE DE NOVO CLASSIFICATION FROM FDA FOR
USE
OF DEEPVIEW SYSTEM, EXPECTS TO SUBMIT REQUEST IN H1 2025
Source text: ID:nGNX91C9Kc
Further company coverage: MDAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectral AI
See all newsBrief: Spectral Ai Receives FDA De Novo Clearance For Deepview® System For Burn Indication
Brief: Spectral Ai Inc - Forecasts Fy2026 Revenue Of About $18.5 Million
Brief: Spectral Ai Names David Mcguire, Cpa, As Chief Financial Officer
Brief: Spectral Ai Names Vincent S. Capone As Chief Executive Officer
Brief: Spectral AI raises $7.6 Million of Additional Growth Capital